Daniel Park is an Infectious Disease physician. ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 W Arbor Dr
Mc 8208
San Diego, CA 921039001
Telephone
619-543-3092Registry record last updated 21 Dec 2010.
Clinical trials
- Randomized Controlled Comparison of Pre-op TLIP vs Intra-op TLIP
Sponsor: Corewell Health East
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20241 payment
- ViiV Healthcare CompanyProgram year202310 payments
- ABBVIE INC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
43.8%Statin23.9%Atorvastatin Calcium100%Part D≥16 patientsCalcium channel blocker13.6%Amlodipine Besylate100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
35.2%Proton pump inhibitor12.5%Omeprazole100%Part D<11 patientsThiazolidinedione8.5%Pioglitazone Hcl100%Part D<11 patients+ 2 more classes in this area
Nervous system
14.2%Tricyclic Antidepressant7.4%Amitriptyline Hcl100%Part D<11 patientsAntihistamine6.8%Hydroxyzine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”